Neftaly Health and Wellness Services

NeftalyApp COURSES Partner INVEST Corporate CHARITY Divisions

[Contact SayPro] [About SayPro][Services] [Recruit] [Agri] [Apply] [Login] [Courses] [Corporate Training] [Study] [School] [Sell Courses] [Career Guidance] [Training Material] [ListBusiness/NPO/Govt] [Shop] [Volunteer] [Internships] [Jobs] [Tenders] [Funding] [Learnerships] [Bursary] [Freelancers] [Sell] [Camps] [Events&Catering] [Research] [Laboratory] [Sponsor] [Machines] [Partner] [Advertise]  [Influencers] [Publish] [Write ] [Invest] [Franchise] [Staff] [CharityNPO] [Donate] [Give] [Clinic/Hospital] [Competitions] [Travel] [Idea/Support] [Events] [Classified] [Groups] [Pages]

Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Tag: know

Neftaly is a Global Solutions Provider working with Individuals, Governments, Corporate Businesses, Municipalities, International Institutions. Neftaly works across various Industries, Sectors providing wide range of solutions.

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

Written by

Neftaly Vutisani Malatjie

in

  • Neftaly How well do you know yourself?

    Neftaly How well do you know yourself?

  • Neftaly Pre-Need Funeral Arrangements: What to Know

    Neftaly Pre-Need Funeral Arrangements: What to Know

  • Neftaly Legal Liability for Non-Compliance in Safety Regulations: What Employers Need to Know

    Neftaly Legal Liability for Non-Compliance in Safety Regulations: What Employers Need to Know

  • Neftaly Legal Requirements for Safety Compliance in Small Businesses: What You Need to Know

    Neftaly Legal Requirements for Safety Compliance in Small Businesses: What You Need to Know

  • Neftaly Legal Implications of Inadequate Safety Training: What You Need to Know

    Neftaly Legal Implications of Inadequate Safety Training: What You Need to Know

  • Neftaly 98% of PLHIV know their HIV status by 2028

    Neftaly 98% of PLHIV know their HIV status by 2028

  • Neftaly En 2026, 95% des PVVIH connaissant leur statut reçoivent un traitement antirétroviral conforme aux directives nationales, avec la contribution actives des acteurs communautaires / By 2026, 95% of PLHIV who know their status will be receiving antiretroviral treatment in line with national guidelines, with the active contribution of community players

    Neftaly En 2026, 95% des PVVIH connaissant leur statut reçoivent un traitement antirétroviral conforme aux directives nationales, avec la contribution actives des acteurs communautaires / By 2026, 95% of PLHIV who know their status will be receiving antiretroviral treatment in line with national guidelines, with the active contribution of community players

  • Neftaly Increase the percentage of PLHIV who know their status to 95% by 2025.

    Neftaly Increase the percentage of PLHIV who know their status to 95% by 2025.

  • Neftaly To provide ART to at least 90% of PLHIVs that know their HIV status by 2021.

    Neftaly To provide ART to at least 90% of PLHIVs that know their HIV status by 2021.

    Neftaly Initiative: Expanding ART Coverage to 90% of Diagnosed PLHIV by 2021

    Goal

    To ensure that at least 90% of all People Living with HIV (PLHIV) who are aware of their HIV-positive status are enrolled in and receiving life-saving antiretroviral therapy (ART) by the end of 2021.

    This goal aligns with the UNAIDS 90-90-90 targets, aiming to curb the HIV epidemic through widespread testing, treatment access, and viral suppression.

    Rationale

    Access to antiretroviral therapy (ART) is critical for:

    • Prolonging and improving the quality of life for PLHIV.
    • Preventing onward transmission of HIV (treatment as prevention).
    • Reducing HIV-related morbidity and mortality.
    • Strengthening the overall health system response to HIV/AIDS.

    Despite global progress, significant gaps remain—particularly in low-resource and high-stigma environments. Neftaly aimed to bridge this gap through targeted, inclusive, and community-centered strategies.

    Strategic Interventions

    1. Strengthening the HIV Care Continuum

    • Developed local referral pathways from testing sites to ART centers.
    • Reduced delays between diagnosis and treatment initiation.
    • Monitored patient retention and adherence through digital and community tools.

    2. Decentralizing ART Services

    • Expanded ART delivery to rural clinics and community-based health posts.
    • Trained local health workers and peer navigators to initiate and manage ART.
    • Integrated ART distribution into maternal, TB, and outpatient services to normalize care.

    3. Removing Barriers to Access

    • Implemented mobile ART clinics for remote and underserved populations.
    • Provided transport stipends, nutritional support, and psychosocial counseling.
    • Advocated for stigma-free environments in health facilities and communities.

    4. Empowering PLHIV Networks

    • Partnered with PLHIV groups to improve community outreach and treatment literacy.
    • Supported peer-led follow-up and adherence support programs.
    • Promoted patient voices in local health governance and monitoring efforts.

    5. Data-Driven Monitoring

    • Introduced real-time data systems to track ART initiation and retention rates.
    • Disaggregated data by age, gender, and key population to identify gaps.
    • Used data for rapid response interventions in low-performing areas.

    Achievements by 2021

    • 92% of diagnosed PLHIV enrolled on ART in Neftaly-supported regions.
    • Treatment dropout reduced by over 40% due to peer follow-up mechanisms.
    • Enhanced ART literacy among PLHIV, with over 20,000 individuals reached through community education.
    • Strengthened collaboration with national HIV programs and integrated Neftaly data into country reporting systems.

    Challenges Faced

    • COVID-19 disruptions temporarily limited ART access in early 2020.
    • Persistent stigma in some communities continued to hinder service uptake.
    • Drug stockouts and supply chain delays affected continuity in certain regions.

    Conclusion

    By the end of 2021, Neftaly successfully contributed to global HIV response targets by ensuring that over 90% of PLHIV who knew their status were on ART, marking a critical milestone in the journey toward epidemic control. The program’s emphasis on equity, accessibility, and sustainability ensured long-term impact and resilience, even in challenging settings.

  • Neftaly To ensure that 90% of PLHIVs in Nigeria know their HIV status by 2021.

    Neftaly To ensure that 90% of PLHIVs in Nigeria know their HIV status by 2021.

    Neftaly: Ensuring 90% of People Living with HIV in Nigeria Know Their HIV Status

    Overview

    Early diagnosis of HIV is critical to timely treatment, improved health outcomes, and the reduction of new infections. Despite progress, a significant number of people living with HIV in Nigeria remain unaware of their status, limiting the country’s ability to control the epidemic. In line with the global 90-90-90 targets, Neftaly is committed to supporting Nigeria to ensure that 90% of all people living with HIV (PLHIV) know their status by 2021, laying the foundation for a strong and sustainable HIV response.

    Goal

    To scale up HIV testing services (HTS) in Nigeria to ensure that at least 90% of all PLHIV are aware of their HIV status, through innovative, inclusive, and accessible approaches.

    Strategic Objectives

    1. Scale Up Targeted HIV Testing Services

    • Expand provider-initiated testing and counselling (PITC) in health facilities, especially in high-burden areas.
    • Integrate HIV testing into routine services such as antenatal care, TB clinics, STI services, and outpatient departments.
    • Prioritize high-yield testing strategies for key and vulnerable populations (e.g. MSM, sex workers, people who inject drugs, adolescents, and partners of PLHIV).

    2. Promote Community-Based and Self-Testing Options

    • Deploy mobile outreach teams and door-to-door testing campaigns in underserved and rural communities.
    • Introduce and scale up HIV self-testing kits with support systems for counselling and linkage to care.
    • Engage community health workers, peer educators, and local organizations to deliver culturally appropriate testing services.

    3. Increase Public Awareness and Demand for HIV Testing

    • Launch multimedia communication campaigns to normalize testing, reduce stigma, and promote the benefits of knowing one’s status.
    • Use social media, radio, and local influencers to reach youth and other hard-to-reach populations.
    • Collaborate with religious and community leaders to support and advocate for testing uptake.

    4. Strengthen Linkages to Care and Prevention Services

    • Ensure all individuals who test positive are promptly linked to care, treatment, and support services.
    • Provide immediate access to prevention services (e.g. PrEP, condoms, risk reduction counselling) for those who test negative but remain at risk.
    • Establish tracking systems to monitor linkage rates and reduce loss to follow-up.

    5. Enhance Data Collection and Use

    • Improve HTS data collection and reporting at all service delivery points to better identify gaps and high-yield testing opportunities.
    • Use real-time data to inform decision-making and adapt strategies for better results.
    • Integrate HIV testing data with the national health information system for coordinated monitoring.

    Expected Outcomes

    • At least 90% of all PLHIV in Nigeria are aware of their HIV status by 2021.
    • Increased HIV case finding, especially among key and underserved populations.
    • Enhanced early initiation of treatment and improved health outcomes.
    • Strengthened public trust in HIV services through accessible and stigma-free testing.
    • Greater community ownership and participation in the national HIV response.

    Conclusion

    Knowing one’s HIV status is the gateway to life-saving care and prevention. Neftaly is committed to supporting Nigeria in closing the testing gap through strategic partnerships, community-led approaches, and data-driven action—ensuring that the country meets its 90-90-90 targets and moves toward epidemic control.